{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:56Z","timestamp":1791233096201,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.eururo.2006.11.045","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T18:01:58Z","timestamp":1165514518000},"page":"1589-1599","source":"Crossref","is-referenced-by-count":34,"title":["The Role of Granulocytes Following Intravesical BCG Prophylaxis"],"prefix":"10.1016","volume":"51","author":[{"given":"Salvatore","family":"Siracusano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ciciliato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bernabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Zabucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.11.045_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavity bacillus Calmette Gu\u00e9rin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-5347(17)55282-9","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy of superficial bladder cancer","volume":"124","author":"Lamn","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00294021","article-title":"Leucocytes in urine after intravesical BCG treatment for superficial bladder cancer: a flow cytofluorimetric analysis","volume":"19","author":"de Boer","year":"1991","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2006.11.045_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2249.1999.00756.x","article-title":"Systemic immune response after intravesical instillation of bacille Calmette-Gu\u00e9rin (BCG) for superficial bladder cancer","volume":"115","author":"Taniguchi","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib5","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1996.14.6.1778","article-title":"Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression","volume":"14","author":"Kaempfer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2006.11.045_bib6","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0022-5347(05)65522-X","article-title":"T helper 1\/2 lymphocyte urynary cytokine profiles in responding and non responding patients after 1 and 2 courses of bacillus Calmette-Gu\u00e9rin for superficial bladder cancer","volume":"166","author":"Saint","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2249.2004.02522.x","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity","volume":"137","author":"Luo","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of TH1 and TH2 cytokines in BCG-induced IFN-production: cytokine promotion and simulation of BCG effect","volume":"21","author":"Luo","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.eururo.2006.11.045_bib9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00326845","article-title":"Changes of the mucosal architecture and urine cytology during BCG treatment","volume":"6","author":"Shapiro","year":"1988","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)39365-5","article-title":"Effects of local bacillus Calmette-Gu\u00e9rin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall","volume":"144","author":"Bohle","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.1987.tb05039.x","article-title":"Local immune responses after intravesical BCG treatment for carcinoma in situ","volume":"60","author":"el-Demiry","year":"1987","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib13","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2005-03-1327","article-title":"Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) results in the release of functional soluble TRAIL\/Apo-2L","volume":"106","author":"Kemp","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.eururo.2006.11.045_bib14","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1158\/0008-5472.CAN-04-0374","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for bacillus Calmette-Gu\u00e9rin-induced antitumor activity","volume":"64","author":"Ludwig","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2006.11.045_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.0019-2805.2003.01794.x","article-title":"Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils","volume":"11","author":"Kamohara","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.eururo.2006.11.045_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1462-5822.2001.00101.x","article-title":"Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract","volume":"3","author":"B\u00e4ckhed","year":"2001","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.eururo.2006.11.045_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1189\/jlb.0103026","article-title":"TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG","volume":"74","author":"Heldwein","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.eururo.2006.11.045_bib18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1464-410X.2006.06026.x","article-title":"Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guerin through Toll-like receptor signalling","volume":"97","author":"Miyazaki","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.11.045_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on [review]","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2006.11.045_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1023\/B:APPT.0000045786.98031.1d","article-title":"Apoptosome dysfunction in human cancer [review]","volume":"9","author":"Hajra","year":"2004","journal-title":"Apoptosis"},{"key":"10.1016\/j.eururo.2006.11.045_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of micrograms quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.eururo.2006.11.045_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0003-9861(92)90060-A","article-title":"Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization","volume":"292","author":"Lungarella","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.eururo.2006.11.045_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jlb.52.6.619","article-title":"A new, one-step assay on whole cell suspensions for peroxidase secretion by human neutrophils and eosinophils","volume":"52","author":"Menegazzi","year":"1992","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.eururo.2006.11.045_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2006.11.045_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/B:IFLA.0000006704.13043.51","article-title":"Identification and subcellular localization of neuronal calcium sensor-1 (NCS-1) in human neutrophils and HL-60 cells","volume":"27","author":"Brochetta","year":"2003","journal-title":"Inflammation"},{"key":"10.1016\/j.eururo.2006.11.045_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00299720","article-title":"Cytostatic effect of different strains of bacillus Calmette-Gu\u00e9rin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha","volume":"20","author":"Rajala","year":"1992","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2006.11.045_bib27","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.4049\/jimmunol.154.8.4157","article-title":"Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils","volume":"154","author":"Sengel\u00f8v","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1084\/jem.143.5.1154","article-title":"The structure of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils","volume":"143","author":"Showell","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.eururo.2006.11.045_bib29","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.4049\/jimmunol.171.12.6680","article-title":"Soluble forms of Toll-like receptor (TLR-2) capable of modulating TLR2 signaling are present in human plasma and breast milk","volume":"171","author":"LeBouder","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF01629431","article-title":"Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells","volume":"118","author":"Huland","year":"1992","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2006.11.045_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF01534428","article-title":"Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy","volume":"39","author":"McAveney","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.eururo.2006.11.045_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2005.05.004","article-title":"BCG dose reduction by decreasing the instillation frequency: effects on local Th1\/Th2 cytokine responses in a mouse model","volume":"48","author":"de Boer","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2006.01.017","article-title":"Management of BCG failures in superficial bladder cancer: a review","volume":"49","author":"Witjes","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.11.045_bib34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/1097-0142(19920115)69:2<537::AID-CNCR2820690242>3.0.CO;2-3","article-title":"Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer","volume":"69","author":"Mizutani","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2006.11.045_bib35","series-title":"Inflammation: basic principles and clinical correlates","first-page":"721","article-title":"Developmental biology of neutrophils and eosinophils","author":"Bainton","year":"1999"},{"key":"10.1016\/j.eururo.2006.11.045_bib36","series-title":"Mechanism of pathogenesis in tuberculosis","first-page":"485","article-title":"Tuberculosis: pathogenesis, protection and control","author":"Rook","year":"1994"},{"key":"10.1016\/j.eururo.2006.11.045_bib37","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.162.5.3037","article-title":"Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract","volume":"162","author":"Hang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib38","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1189\/jlb.69.6.899","article-title":"Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection","volume":"69","author":"Godaly","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.eururo.2006.11.045_bib39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CDLI.11.5.969-976.2004","article-title":"Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells","volume":"11","author":"Shimizu","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib40","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.4049\/jimmunol.165.9.5287","article-title":"Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice","volume":"165","author":"Godaly","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.eururo.2006.11.045_bib41","series-title":"Inflammation: basic principles and clinical correlates","first-page":"721","article-title":"Oxygen metabolites form phagocytes","author":"Klebanoff","year":"1999"},{"key":"10.1016\/j.eururo.2006.11.045_bib42","series-title":"Inflammation: basic principles and clinical correlates","first-page":"801","article-title":"Oxygen-independent antimicrobial systems of phagocytes","author":"Elsbach","year":"1999"},{"key":"10.1016\/j.eururo.2006.11.045_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1462-5822.2004.00489.x","article-title":"Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation","volume":"7","author":"Godaly","year":"2005","journal-title":"Cell Microbiol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806014771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806014771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T22:22:48Z","timestamp":1683670968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806014771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0302283806014771"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.11.045","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}